XML 92 R41.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of expense for income taxes The expense for income taxes consists of the following:
20252024
Current
Federal$— $— 
State— — 
Foreign2,000 — 
Total current expense2,000 — 
Deferred
Federal— — 
State— — 
Foreign— — 
Total deferred expense— — 
Total income tax expense$2,000 $— 
Reconciliation of effective income tax rate
A reconciliation of the U.S. federal statutory rate to the Company’s effective income tax rate for the year ended December 31, 2025 and December 31, 2024 is as follows:
Twelve Months Ended December 31, 2025Period from September 19, 2024 (Inception) Through December 31, 2024
U.S. Federal statutory tax rate$(31,908)21 %$(3,752)21 %
Foreign Tax Effects
China
Withholding taxes2,000 (1.3)%— — %
Tax credits(1,809)1.2 %(46)0.3 %
Change in valuation allowance34,697 (22.9)%3,612 (20.2)%
Nontaxable or nondeductible items870 (0.6)%186 (1.0)%
Other adjustments
Tax deductible merger expenses(1,850)1.2 %— — %
Effective income tax rate$2,000 (1.4)%$— 0.1 %
Schedule of income tax effect of temporary differences and carryforwards
The income tax effect of each type of temporary difference and carryforward as of December 31, 2025 and December 31, 2024 was as follows:
Twelve Months Ended December 31, 2025Period from September 19, 2024 (Inception) Through December 31, 2024
Deferred tax assets:
Net operating loss carryforwards$12,164 $444 
Tax credit carryforwards2,423 73 
Accrued liabilities1,246 
Lease liability433 — 
Capitalized research and development costs5,867 1,724 
Intangible assets23,439 1,466 
Share-based compensation2,801 229 
Fixed assets— 
Total deferred tax assets48,378 3,940 
Valuation allowance(47,991)(3,940)
Deferred tax assets, net of valuation allowance387 — 
Deferred tax liabilities:
Right of use asset(387)— 
Total deferred tax liabilities(387)— 
Deferred taxes, net$— $—